165 related articles for article (PubMed ID: 36522277)
1. Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel.
Solanki AA; Puckett LL; Kujundzic K; Katsoulakis E; Park J; Kapoor R; Hagan M; Kelly M; Palta J; Ballas LK; DeMarco J; Hoffman KE; Lawton CAF; Michalski J; Potters L; Zelefsky M; Kudner R; Dawes S; Wilson E; Sandler H
Pract Radiat Oncol; 2023; 13(2):e149-e165. PubMed ID: 36522277
[TBL] [Abstract][Full Text] [Related]
2. Consensus Quality Measures and Dose Constraints for Lung Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and ASTRO Expert Panel.
Puckett LL; Titi M; Kujundzic K; Dawes SL; Gore EM; Katsoulakis E; Park JH; Solanki AA; Kapoor R; Kelly M; Palta J; Chetty IJ; Jabbour SK; Liao Z; Movsas B; Thomas CR; Timmerman RD; Werner-Wasik M; Kudner R; Wilson E; Simone CB
Pract Radiat Oncol; 2023; 13(5):413-428. PubMed ID: 37075838
[TBL] [Abstract][Full Text] [Related]
3. Consensus Quality Measures and Dose Constraints for Breast Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel.
Puckett LL; Kodali D; Solanki AA; Park JH; Katsoulakis E; Kudner R; Kapoor R; Kujundzic K; Chapman CH; Hagan M; Kelly M; Palta J; Bazan JG; Dragun A; Fisher C; Haffty B; Nichols E; Shah C; Salehpour M; Dawes S; Wilson E; Buchholz TA
Pract Radiat Oncol; 2023; 13(3):217-230. PubMed ID: 36115498
[TBL] [Abstract][Full Text] [Related]
4. Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel.
Park J; Venkatesulu BP; Kujundzic K; Katsoulakis E; Solanki AA; Puckett LL; Kapoor R; Chapman CH; Hagan M; Kelly MD; Palta J; Ashman JB; Jacqmin D; Kachnic LA; Minsky BD; Olsen J; Raldow AC; Wo JY; Dawes S; Wilson E; Kudner R; Das P
Pract Radiat Oncol; 2022; 12(5):424-436. PubMed ID: 35907764
[TBL] [Abstract][Full Text] [Related]
5. Consensus Quality Measures and Dose Constraints for Head and Neck Cancer with an emphasis on Oropharyngeal and Laryngeal Cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel.
Katsoulakis E; Kudner R; Chapman C; Park J; Puckett L; Solanki A; Kapoor R; Hagan M; Kelly M; Palta J; Tishler R; Hitchcock Y; Chera B; Feygelman V; Walker G; Sher D; Kujundzic K; Wilson E; Dawes S; Yom SS; Harrison L
Pract Radiat Oncol; 2022; 12(5):409-423. PubMed ID: 35667551
[TBL] [Abstract][Full Text] [Related]
6. Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Quality Measures Initiative.
Park J; Puckett LL; Katsoulakis E; Venkatesulu BP; Kujundzic K; Solanki AA; Movsas B; Simone CB; Sandler H; Lawton CA; Das P; Wo JY; Buchholz TA; Fisher CM; Harrison LB; Sher DJ; Kapoor R; Chapman CH; Dawes S; Kudner R; Wilson E; Hagan M; Palta J; Kelly MD
Pract Radiat Oncol; 2022; 12(6):468-474. PubMed ID: 35690354
[TBL] [Abstract][Full Text] [Related]
7. VA-Radiation Oncology Quality Surveillance Program.
Hagan M; Kapoor R; Michalski J; Sandler H; Movsas B; Chetty I; Lally B; Rengan R; Robinson C; Rimner A; Simone C; Timmerman R; Zelefsky M; DeMarco J; Hamstra D; Lawton C; Potters L; Valicenti R; Mutic S; Bosch W; Abraham C; Caruthers D; Brame R; Palta JR; Sleeman W; Nalluri J
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):639-647. PubMed ID: 31983560
[TBL] [Abstract][Full Text] [Related]
8. Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries : A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO).
Shelan M; Aebersold DM; Albrecht C; Böhmer D; Flentje M; Ganswindt U; Höcht S; Hölscher T; Müller AC; Niehoff P; Pinkawa M; Schmidt-Hegemann NS; Sedlmayer F; Wolf F; Zamboglou C; Zips D; Wiegel T; Ghadjar P
Strahlenther Onkol; 2021 Nov; 197(11):993-1000. PubMed ID: 34463814
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline.
Morgan SC; Hoffman K; Loblaw DA; Buyyounouski MK; Patton C; Barocas D; Bentzen S; Chang M; Efstathiou J; Greany P; Halvorsen P; Koontz BF; Lawton C; Leyrer CM; Lin D; Ray M; Sandler H
Pract Radiat Oncol; 2018; 8(6):354-360. PubMed ID: 30322661
[TBL] [Abstract][Full Text] [Related]
10. Development of Quality Indicators for the Care of Women with Abnormal Uterine Bleeding by Primary Care Providers in the Veterans Health Administration.
Washington DL; Danz M; Jackson L; Cordasco KM
Womens Health Issues; 2019; 29(2):135-143. PubMed ID: 30563732
[TBL] [Abstract][Full Text] [Related]
11. Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel.
Cox JD; Gallagher MJ; Hammond EH; Kaplan RS; Schellhammer PF
J Clin Oncol; 1999 Apr; 17(4):1155. PubMed ID: 10561174
[TBL] [Abstract][Full Text] [Related]
12. Erratum to: Katsoulakis E, Kudner R, Chapman C, et al. Consensus Quality Measures and Dose Constraints for Head and Neck Cancer with an emphasis on Oropharyngeal and Laryngeal Cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel. Pract Radiat Oncol. 2022; 12(5):409-423.
Pract Radiat Oncol; 2023; 13(5):e460-e469. PubMed ID: 37652624
[No Abstract] [Full Text] [Related]
13. Depression Quality of Care: Measuring Quality over Time Using VA Electronic Medical Record Data.
Farmer MM; Rubenstein LV; Sherbourne CD; Huynh A; Chu K; Lam CA; Fickel JJ; Lee ML; Metzger ME; Verchinina L; Post EP; Chaney EF
J Gen Intern Med; 2016 Apr; 31 Suppl 1(Suppl 1):36-45. PubMed ID: 26951274
[TBL] [Abstract][Full Text] [Related]
14. Quality indicators in radiation oncology: proposal of the Spanish Society of Radiation Oncology (SEOR) for a continuous improvement of the quality of care in oncology.
López Torrecilla J; Marín I Borràs S; Ruiz-Alonso A; Jaen Olasolo J; Vázquez de la Torre ML; Bóveda Carro E; Rodríguez A; Ignacio García E; Caballero Martínez F; Campos Lucas FJ; Lara Jiménez PC; Martínez JC; Ferrer Albiach C
Clin Transl Oncol; 2019 Apr; 21(4):519-533. PubMed ID: 30311145
[TBL] [Abstract][Full Text] [Related]
15. Development of binational radiation therapy quality indicator reports for prostate cancer treatment using registry data.
Chmiel E; Pase M; Evans M; Johnson M; Millar J; Papa N
J Med Imaging Radiat Oncol; 2022 Dec; 66(8):1097-1105. PubMed ID: 36251627
[TBL] [Abstract][Full Text] [Related]
16. Contemporary prostate cancer radiation therapy in the United States: Patterns of care and compliance with quality measures.
Lee DJ; Barocas DA; Zhao Z; Huang LC; Koyama T; Resnick MJ; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF; Hoffman KE
Pract Radiat Oncol; 2018; 8(5):307-316. PubMed ID: 30177030
[TBL] [Abstract][Full Text] [Related]
17. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
18. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline.
Morgan SC; Hoffman K; Loblaw DA; Buyyounouski MK; Patton C; Barocas D; Bentzen S; Chang M; Efstathiou J; Greany P; Halvorsen P; Koontz BF; Lawton C; Leyrer CM; Lin D; Ray M; Sandler H
J Urol; 2019 Mar; 201(3):528-534. PubMed ID: 30759696
[TBL] [Abstract][Full Text] [Related]
20. Is moderate hypofractionation accepted as a new standard of care in north america for prostate cancer patients treated with external beam radiotherapy? Survey of genitourinary expert radiation oncologists.
McClelland S; Sandler KA; Degnin C; Chen Y; Hung AY; Mitin TE
Int Braz J Urol; 2019; 45(2):273-287. PubMed ID: 30676300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
